Asher Biotherapeutics

Asher Biotherapeutics is a biotechnology company pioneering a new approach to immunotherapy with their cis-targeted immunotherapies. Their platform enables highly selective activation of specific immune cell types, targeting only those that drive the desired therapeutic response. This addresses the shortcomings of conventional immunotherapies, which often indiscriminately act on multiple cell types, resulting in suboptimal efficacy and side effects. Asher Bio's mission is to develop medicines that restore hope, health, and happiness in the lives of patients.

The company's lead program, AB248, is a cis-targeted IL-2 immunotherapy that specifically activates CD8+ effector T cells, showing promising anti-tumor activity in preclinical models. Asher Bio is also developing AB821, a CD8-targeted IL-21 immunotherapy, and is exploring the use of their cis-targeting platform to create immunotherapies for a variety of indications including cancer, autoimmune disease, and infectious disease. The company has a strong team of experienced scientists and executives with a deep understanding of immunotherapy and a shared commitment to making a difference for patients.

Asher Biotherapeutics offers flexible work arrangements, allowing employees to work remotely from home or come into the office depending on their preference and manager's approval. Additionally, the company provides flexible PTO, allowing employees to take as much time off as they need with manager approval.

Asher Bio offers a competitive benefits package, including flexible PTO, flexible working arrangements, 90% covered medical, dental and vision plans with FSA and HSA options, a 401(k) plan with company contributions, and additional benefits like cell phone reimbursement, life insurance, FMLA at 100% pay, LTD, and EAP.

Asher Biotherapeutics is a biotechnology company focused on developing precisely targeted immunotherapies for cancer, autoimmune, and infectious diseases. Their mission is to develop therapies engineered to overcome the limitations of existing immune-based treatments by selectively activating specific immune cell types with validated disease fighting functionality. Their aim is to deliver a new class of highly selective, cis-targeted immunotherapies that are designed to activate only the desired immune cell type to maximize efficacy and limit off-target toxicities, ultimately restoring hope, health, and happiness in the lives of patients.

Asher Bio fosters a culture that is driven by a shared passion for innovation, collaboration, and making a tangible difference in patients' lives. They are committed to rigorous decision-making, enthusiastic execution, and inspired innovation while maintaining an inclusive and respectful work environment. Their values are evident in the company's name "Asher," which translates to "happy, blessed, and fortunate" in Hebrew, reflecting their mission to restore hope, health, and happiness to patients. The company's team is described as energetic, hardworking, and supportive, with a strong sense of caring for patients and each other.

Asher Bio is committed to building a diverse, equitable, and inclusive workplace where all employees feel valued, respected, and empowered to contribute their unique perspectives and talents. The company actively fosters a culture of belonging and encourages open dialogue, recognizing the importance of representation across all levels and functions. Asher Bio seeks to attract, develop, and retain a diverse workforce through a variety of initiatives, including a robust employee resource group program, inclusive recruitment practices, and ongoing diversity training. This commitment to DE&I is central to Asher Bio's mission of restoring hope, health, and happiness in the lives of patients by creating a dynamic and innovative environment for all.